Primary biliary cholangitis patients exhibit MRI changes in structure and function of interoceptive brain regions

PLoS One. 2019 Feb 8;14(2):e0211906. doi: 10.1371/journal.pone.0211906. eCollection 2019.

Abstract

Background: Many patients with primary biliary cholangitis (PBC) experience non-hepatic symptoms that are possibly linked to altered interoception, the sense of the body's internal state. We used magnetic resonance imaging (MRI) to determine if PBC patients exhibit structural and functional changes of the thalamus and insula, brain regions that process signals related to interoception.

Methods: Fifteen PBC patients with mild disease and 17 controls underwent 3 Tesla T1-weighted MRI, resting-state functional MRI, and quantitative susceptibility mapping (QSM), to measure thalamic and insular volume, neuronal activity and iron deposition, respectively. Group differences were assessed using analysis of covariance, and stepwise linear regression was used to determine the predictive power of clinical indicators of disease.

Results: PBC patients exhibited reduced thalamic volume (p < 0.01), and ursodeoxycholic acid (UDCA) non-responders exhibited lower left thalamus activity (p = 0.05). PBC patients also exhibited reduced anterior insula activity (p = 0.012), and liver stiffness positively correlated with MRI indicators of anterior insula iron deposition (p < 0.02).

Conclusions: PBC affects structure and function of brain regions critically important to interoception. Moreover, these brain changes occur in patients with early, milder disease and thus may potentially be reversible.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Brain Mapping
  • Case-Control Studies
  • Cerebral Cortex / diagnostic imaging*
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism
  • Cerebral Cortex / physiopathology
  • Cholagogues and Choleretics / therapeutic use
  • Female
  • Humans
  • Interoception / drug effects
  • Interoception / physiology
  • Iron / metabolism*
  • Linear Models
  • Liver / diagnostic imaging*
  • Liver / drug effects
  • Liver / metabolism
  • Liver / physiopathology
  • Liver Cirrhosis, Biliary / diagnostic imaging*
  • Liver Cirrhosis, Biliary / drug therapy
  • Liver Cirrhosis, Biliary / metabolism
  • Liver Cirrhosis, Biliary / physiopathology
  • Magnetic Resonance Imaging
  • Middle Aged
  • Organ Size
  • Severity of Illness Index
  • Thalamus / diagnostic imaging*
  • Thalamus / drug effects
  • Thalamus / metabolism
  • Thalamus / physiopathology
  • Ursodeoxycholic Acid / therapeutic use

Substances

  • Cholagogues and Choleretics
  • Ursodeoxycholic Acid
  • Iron

Grants and funding